Treatment Modalities for Basal Like Breast Cancer

Journal Title: Journal of Medical Science And clinical Research - Year 2014, Vol 2, Issue 12

Abstract

Breast cancer represents a heterogeneous group of disorders with significant morbidity and mortality among female population. Basal like breast cancer represents one of the several sub types of breast cancer. It has always been considered synonymous to triple negative breast cancer but studies have repeatedly proven it and triple negative to be two separate entities having different immunohisto chemistry, clinical behavior and prognosis. Basal like breast cancer represents an immunophenotype similar to triple negative breast cancer in a respect that it lacks estrogen receptors (ER), progesterone receptors (PR) and human epithelial growth factor 2 (HER2) overexpression, but is quite distinct at the same time as it represents additional biomarkers as well like cytokeratins 5/6 and epithelial growth factor receptors (EGFR). Moreover, basal like breast cancers is characterized as tumors with greater degree of atypia, higher propensity of local invasion, easy distant metastasis and grim prognosis. Even when it represent as much as 13-37% of breast cancer burden in young female population, definite treatment protocols remain lacking. Thorough analysis of currently available data in this regard has shown that breast conserving therapy (BCT) with adjuvant radiotherapy promises the best outcomes. In addition, preoperative use of chemotherapeutic agents like paclitaxel followed by 5-fluorouracil, doxorubicin, and cyclophosphamide and post-operative use of anthracycline (doxorubicin/cyclophosphamide or fluorouracil/doxorubicin/cyclophosphamide) and CMF based (Cyclophosphamide, Methotrexate, and Fluorouracil) adjuvant chemotherapy has shown to improve the prognosis. Furthermore, therapies that target features like dysfunction of BRCA1 and overexpression of EGFR are currently being studied as potential treatment options.

Authors and Affiliations

Dr. Adnan Bashir MD Bhatti,

Keywords

Related Articles

Supraclavicular lymphadenopathy: Cytopathological study of 3 years with Review of Literature

Background: Fine needle aspiration cytology of enlarged lymph nodes has evolved as a first line of investigation in diagnosis of spectrum of lesions. Supraclavicular Lymphadenopathy can be due to many pathological condit...

Prediction of Neonatal Seizures in HIE by APGAR Score and Umbilical Cord Blood pH

Background: Hypoxic Ischemic Encephalopathy (HIE) due to Perinatal asphyxia is one of the commonest cause of symptomatic seizures in newborn period. In fact, about two-thirds of cases of neonatal seizures are due to HIE....

Comparison of Efficacy of Myofascial Release and Positional Release Therapy in Tension Type Headache

Study objectives: Comparison of efficacy of Myofascial release and positional release therapy in tension type headache. Design: Comparative study. Setting: All the subjects were included from various clinics, hospitals a...

Comparison of Epidural Steroid and Gabapentinin Lumbosacral Pain

Purpose: To evaluate whether an epidural steroid injection or gabapentin is a better treatment for lumbosacral radiculopathy in 150 patients. Material and methods: A prospective intervention study was done on 150 patient...

Distribution and effect of APO E genotype on plasma lipid in non-obese and obese in north Indian population

Introduction: Apolipo protein E (apo E) plays key role in lipid metabolism, obesity and accordingly in development of diabetes and coronary heart disease (CHD). Methods: Apo E polymorphism was performed using polymerase...

Download PDF file
  • EP ID EP208104
  • DOI -
  • Views 49
  • Downloads 0

How To Cite

Dr. Adnan Bashir MD Bhatti, (2014). Treatment Modalities for Basal Like Breast Cancer. Journal of Medical Science And clinical Research, 2(12), 3496-3508. https://europub.co.uk/articles/-A-208104